UCI: Tour de France champion, Froome failed drugs test

Four-time Tour de France winner Chris Froome. (AFP)

Union Cycliste Internationale (UCI), cycling’s governing body, said on Wednesday, that four-time Tour de France winner Chris Froome failed a drugs test during the Vuelta race in September.

The UCI did not suspend Froome from competing, but asked the British Team Sky driver to provide more information on violating the permitted level of legal asthma medication Salbutamol in his system.

The team said he had taken no more than the permissible amount of Salbutamol, adding that Froome had declared his use of the medication.

The 32-year-old rider suffered from asthma since childhood and had been affected by symptoms during the Vuelta a Espana, the Tour of Spain, which he went on to win.

Froome did not participate in any tournament since then, but he declared his intention to take part in the three major tours, France, Spain and Italy, in 2018.

The views expressed in Op-Ed pieces are those of the author and do not purport to reflect the opinions or views of Libyan Express.
How to submit an Op-Ed: Libyan Express accepts opinion articles on a wide range of topics. Submissions may be sent to oped@libyanexpress.com. Please include ‘Op-Ed’ in the subject line.

Submit a Correction

For: UCI: Tour de France champion, Froome failed drugs test

Your suggestion have been successfully submitted

There was an error while trying to send your request. Please try again.

Libyan Express will use the information you provide on this form to be in touch with you and to provide updates and marketing.